investordatabase.org

Avoro Capital Advisors LLC

avorocapital.com Direct + LP

Avoro Capital Advisors is a global life sciences investment firm that invests in public and private biotechnology companies, with a focus on supporting emerging companies and advancing biopharmaceutical innovation.

Avoro Capital Advisors LLC is an investor headquartered in New York, United States. It invests both directly in companies and in funds as a limited partner, from pre-seed to growth, in biotechnology, life sciences and biopharmaceutical.

“Avoro Capital is a global life sciences investment firm with a focus on supporting emerging biotechnology companies.”

Avoro Capital Advisors LLC, own website
Layer
Direct + LP
Type
Other
Stage
Pre-seedGrowth
Headquarters
New York, United States
Invests in
global
Sectors
biotechnology, life sciences, biopharmaceutical

Team, as Avoro Capital Advisors LLC publishes it

  • Behzad Aghazadeh Managing Partner & Portfolio Manager
  • Neil Cammarosano Chief Financial Officer
  • Matthew Canver Director
  • Diane Chien Hedge Fund Controller
  • Mark Chin Investment Partner - Avoro Ventures
  • Uya Chuluunbaatar Investment Partner – Avoro Ventures
  • Scott Epstein Partner, Chief Operating Officer & Chief Compliance Officer
  • Lauren Godlasky Head of Investor Relations & Marketing

Names and roles exactly as listed on avorocapital.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 49 co-investors found.

  • RA Capital Management 7 shared companies: ascendispharma.com, hemab.com, vividion.com, bellicum.com…
  • Sofinnova Investments, INC. 7 shared companies: ascendispharma.com, apellis.com, merus.nl, amarincorp.com…
  • Foresite Capital 6 shared companies: ascendispharma.com, adaptimmune.com, bellicum.com, allogene.com…
  • Frazier Life Sciences Management, LP 6 shared companies: acerta-pharma.com, aviditybiosciences.com, scorpiontx.com, amicusrx.com…
  • Atlas Venture 5 shared companies: ethyrealbio.com, intelliatx.com, kymeratx.com, horizontherapeutics.com…
  • Bain Capital Life Sciences 5 shared companies: kymeratx.com, olema.com, amylyx.com, nuvalent.com…
  • Aisling Capital Management LP 4 shared companies: ascendispharma.com, syndax.com, gbt.com, monterosatx.com
  • F-Prime Capital 4 shared companies: apellis.com, adaptimmune.com, aviditybiosciences.com, zogenix.com
  • OrbiMed 4 shared companies: scribetx.com, corvuspharma.com, ottimopharma.com, vanquabio.com
  • EcoR1 Capital 4 shared companies: kuraoncology.com, intelliatx.com, scorpiontx.com, syndax.com

and 39 more — the graph.

Where this comes from

Every fact above was read from a page Avoro Capital Advisors LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 5907 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under